Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

LIDOCAINE AND PRILOCAINE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

65 API Suppliers, 19 USDMF, 7 CEP/COS, 5 JDMF, 6 EU WC, 9 KDMF, 22 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

159 Drugs in Development

159 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

384 FDF Dossiers, 55 FDA Orange Book, 215 Europe, 21 Canada, 3 Australia, 14 South Africa, 76 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, PATCH;TOPICAL - 5%, PATCH;TOPICAL - 70MG;70MG, CREAM;TOPICAL - 7%;7%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Evonik, 3 Rochem International Inc, 12 SPI Pharma, 20 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Kewpie Corporation, 23 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 17 Kirsch Pharma, 4 ACG Worldwide, 17 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 52 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 5 CD Formulation, 3 Clariant, 13 Corel Pharma Chem, 1 DFE Pharma, 3 Doshion Polyscience, 3 Esteem Industries, 5 Finar, 18 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 5 Kerry, 3 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 8 Lubrizol Life Science Health, 17 Microlex e.U, 4 Nanjing Bold Chemical, 3 Nippon Fine Chemical, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 19 Roquette, 16 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 2 Silverline Chemicals, 2 Symrise, 1 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

89 Topical, 76 Solubilizers, 61 Thickeners and Stabilizers, 57 Fillers, Diluents & Binders, 53 Parenteral, 39 Emulsifying Agents, 31 Coating Systems & Additives, 31 Disintegrants & Superdisintegrants, 29 Direct Compression, 28 Film Formers & Plasticizers, 26 Lubricants & Glidants, 25 Granulation, 24 Surfactant & Foaming Agents, 20 Controlled & Modified Release, 19 Taste Masking, 15 Rheology Modifiers, 12 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 8 Empty Capsules, 7 API Stability Enhancers, 2 Coloring Agents, 1 Dry Powder Inhalation, 1 Soft Gelatin

DIGITAL CONTENT

117 News #PharmaBuzz

117 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 68 Regulatory FDF Prices, 4 Annual Reports

MARKET PLACE

31 APIs, 24 FDF Dossiers

PATENTS & EXCLUSIVITIES

11 US Patents, 1 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 33 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Swati Spentose	India	Daeshin Pharmaceutical Co., Ltd.	20201013-210-J-408	lidocaine	2020-10-13	Swati Spentose Private Limited (Unit-I)	India	Plot No. A-1/2102 & 2103, Phase III, GIDC, VAPI, City: Vapi - 396 195, Dist: Valsad, Gujarat State India
29/11/2025	Delta Synthetic Co. Ltd	Taiwan	SG Biochem Co., Ltd.	20210426-211-J-705(3)	lidocaine	2021-12-17	Delta Synthetic Co., Ltd.	Taiwan	15, Minsheng St., Tucheng Dist., New Taipei City 23679, Taiwan, ROC

LIDOCAINE AND PRILOCAINE

LIDOCAINE AND PRILOCAINE

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

65 API Suppliers

19 USDMF

7 CEP/COS

5 JDMF

6 EU WC

9 KDMF

22 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

159 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

384 FDF Dossiers

55 FDA Orange Book

215 Europe

21 Canada

3 Australia

14 South Africa

76 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 2.5%;2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

PATCH;TOPICAL - 5%

PATCH;TOPICAL - 70MG;70MG

CREAM;TOPICAL - 7%;7%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

3 Evonik

3 Rochem International Inc

12 SPI Pharma

20 DKSH

1 PMC Isochem

1 Pharm-RX Chemical

9 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

2 Kewpie Corporation

23 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 Capital Farma

17 Kirsch Pharma

4 ACG Worldwide

17 Actylis

3 Aeon Procare

2 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

52 BASF

1 Bioplus Life Sciences

1 BioSpectra

5 CD Formulation

3 Clariant

13 Corel Pharma Chem

1 DFE Pharma

3 Doshion Polyscience

3 Esteem Industries

5 Finar

18 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

1 Ideal Cures

3 Ingredion Pharma Solutions

5 Kerry

3 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

8 Lubrizol Life Science Health

17 Microlex e.U

4 Nanjing Bold Chemical

3 Nippon Fine Chemical

1 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

CREAM;TOPICAL - 2.5%;2.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons